Checkmate Capital

Type

Venture Capital

Status

Active

Location

Los Angeles, United States

Total investments

9

Average round size

2M

Portfolio companies

8

Rounds per year

1.50

Lead investments

5

Follow on index

0.11

Exits

1

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyAnalyticsInformation TechnologyHealth CareMedical DeviceLife SciencePharmaceuticalOil and GasClinical Trials

Summary

Checkmate Capital appeared to be the VC, which was created in 2017. The company was established in North America in United States. The main department of described VC is located in the Los Angeles.

Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Oil and Gas, Life Science. Among the most popular portfolio startups of the fund, we may highlight bcause, TELA Bio. The fund has no specific favorite in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

The overall number of key employees were 4.

The higher amount of exits for fund were in 2019. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2018. The usual things for fund are deals in the range of 5 - 10 millions dollars. Speaking about the real fund results, this VC is 80 percentage points more often commits exit comparing to other organizations.

The standard case for the fund is to invest in rounds with 1 partaker. Despite the Checkmate Capital, startups are often financed by Signet Healthcare Partners, SBI Group, Quaker Partners.

Show more

Investor highlights

Industry focus
Biotech/Life SciencesClimate techAgriculture
Geo focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
9
Lead investments
5
Exits
1
Rounds per year
1.50
Follow on index
0.11
Investments by industry
  • Biotechnology (7)
  • Health Care (2)
  • Medical Device (2)
  • Pharmaceutical (1)
  • Life Science (1)
  • Show 4 more
Investments by region
  • United States (6)
  • Canada (2)
  • South Korea (1)
Peak activity year
2020

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
6
Avg. valuation at time of investment
625K
Group Appearance index
0.67

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Bredis 19 May 2023 Information Technology, Medical Device, Clinical Trials Seed Seoul, Seoul-t'ukpyolsi, South Korea

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.